Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
121 Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
122 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
123 Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma Department of Radiotherapy and Nuclear medicine Prof. Mostafa El-Sayed Abdalones Mohamed 2021
124 Pattern of Pediatric Soft Tissue and Bone Sarcomas at South
Egypt Cancer Institute, Retrospective Study 		Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2021
125 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Department of Pathology Saly Salah Abdelhakeem 2021
126 Association of robust radiomic features from staging18F-FDG PET/CT in lung cancer with EGFR over expression and overall survival Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
127 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Department of Medical Oncology Dr. Hanaan Ahmed Mohammed Ahmed 2021
128 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Alia Mohamed Ali Attia 2021
129 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2021
130 Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin Department of Radiotherapy and Nuclear medicine Dr. Ayat allah Ali yousseif 2021